.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Farmers Insurance
Chinese Patent Office
Medtronic
Deloitte
Boehringer Ingelheim
Cerilliant
US Army
Moodys
Healthtrust

Generated: November 21, 2017

DrugPatentWatch Database Preview

Cspc Ouyi Pharm Co Company Profile

« Back to Dashboard

What is the competitive landscape for CSPC OUYI PHARM CO, and what generic and branded alternatives to CSPC OUYI PHARM CO drugs are available?

CSPC OUYI PHARM CO has eight approved drugs.



Summary for Cspc Ouyi Pharm Co

US Patents:0
Tradenames:6
Ingredients:6
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cspc Ouyi Pharm Co
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET, EXTENDED RELEASE;ORAL078321-002Apr 17, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
MONTELUKAST SODIUM
montelukast sodium
TABLET, CHEWABLE;ORAL209011-001Apr 18, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
CLOPIDOGREL BISULFATE
clopidogrel bisulfate
TABLET;ORAL204359-001Feb 2, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL202114-002Jul 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
TRAMADOL HYDROCHLORIDE
tramadol hydrochloride
TABLET;ORAL091498-001Mar 29, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET;ORAL205096-003Jul 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
MONTELUKAST SODIUM
montelukast sodium
TABLET;ORAL209012-001Apr 24, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
DONEPEZIL HYDROCHLORIDE
donepezil hydrochloride
TABLET;ORAL202114-001Jul 5, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET;ORAL205096-002Jul 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Cspc Ouyi Pharm Co
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET;ORAL205096-001Jul 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Julphar
Boehringer Ingelheim
Merck
US Army
Medtronic
McKinsey
Chubb
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot